SunMed Holdings (US) announced a strategic partnership with Securisyn Medical LLC (US) to enhance ventilated patient safety and broader smooth tube and catheter security. Browse 235 market data Tables and 43 Figures spread through 295 Pages and in-depth TOC on “Airway Management Devices Market by type (Endotracheal tubes, Tracheostomy tube, Oropharyngeal, Nasopharyngeal, Laryngoscopes, Resuscitators), Application […]
Tag: Pharmaceuticals & Biotech
Type 1 Diabetes Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers
DelveInsight’s, “Type 1 Diabetes Pipeline Insight 2024” report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in the Type 1 Diabetes pipeline landscape. It covers the Type 1 Diabetes pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Type 1 Diabetes pipeline therapeutics assessment by product type, stage, route […]
RNA Interference Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers
DelveInsight’s, “RNA Interference Pipeline Insight 2024” report provides comprehensive insights about 20+ companies and 90+ pipeline drugs in the RNA Interference pipeline landscape. It covers the RNA Interference pipeline drug profiles, including clinical and nonclinical stage products. It also covers the RNA Interference pipeline therapeutics assessment by product type, stage, route of administration, and molecule […]
Primary Hyperoxyaluria Clinical Trials 2024: FDA Approvals, Medication, Treatment Market, Therapies, MOA, ROA, Companies by DelveInsight | Dicerna Pharma, Allena Pharma, Genentech, Biocode, Alnylum
Primary Hyperoxyaluria Clinical Trials Primary Hyperoxaluria pipeline constitutes 6+ key companies continuously working towards developing 6+ Primary Hyperoxaluria treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. (Albany, United States) “Primary Hyperoxaluria Pipeline Insight, 2024“ report by DelveInsight outlines comprehensive insights into the present clinical development scenario and […]
Pompe Disease Market on Track for Major Expansion by 2034, According to DelveInsight | Asklepios Biopharma, Genzyme, Sanofi, GeneCradle Inc, Astellas Gene Therapies, Amicus Therapeutics, Spark
The Key Pompe Disease Companies in the market include – Asklepios Biopharmaceutical, Genzyme, Sanofi, GeneCradle Inc, Astellas Gene Therapies, Amicus Therapeutics, Spark Therapeutics, Inc., Asklepios Biopharmaceutical, and others. DelveInsight’s “Pompe Disease Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Pompe Disease, historical and forecasted epidemiology as well as the […]
Chronic Hand Eczema Market Expected to Experience Major Growth by 2034, According to DelveInsight | Basilea Pharma, Stiefel Labs, LEO Pharma, Asana Biosciences, Incyte
The Key Chronic Hand Eczema Companies in the market include – Basilea Pharmaceutica/ Stiefel Laboratories, LEO Pharma, Asana Biosciences and Incyte Corporation, and others. The Chronic Hand Eczema market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Chronic Hand Eczema pipeline products […]
Prader-Willi Syndrome Market Forecasted to Surge in Coming Years, 2024-2034 Analysis by DelveInsight | Novo Nordisk, Pfizer, Sandoz, Harmony Biosciences, Soleno Therapeutics, Harmony Biosciences
DelveInsight’s “Prader-Willi Syndrome Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Prader-Willi Syndrome, historical and forecasted epidemiology as well as the Prader-Willi Syndrome market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Prader-Willi Syndrome market […]
Tenosynovial Giant Cell Tumors Pipeline Insights and Analysis 2024: FDA Approvals, Therapies, MOA, ROA, and Developments | Deciphera Pharma, Elixiron Immunotherapeutics, Daiichi Sankyo, Abbisko Thera
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Tenosynovial Giant Cell Tumors pipeline constitutes 5+ key companies continuously working towards developing 5+ Tenosynovial Giant Cell Tumors treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. “Tenosynovial Giant Cell Tumors Pipeline Insight, 2024“ report by DelveInsight […]
Hematopoietic Stem Cell Transplantation Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | Sanofi, Actinium Pharma, Medexus Pharma, medac Pharma, Actinium Pharma
The Hematopoietic Stem Cell Transplantation market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Hematopoietic Stem Cell Transplantation pipeline products will significantly revolutionize the Hematopoietic Stem Cell Transplantation market dynamics. DelveInsight’s “Hematopoietic Stem Cell Transplantation Market Insights, Epidemiology, and Market Forecast-2034″ report […]
Increasing Prevalence of Chronic Diseases Driving Pharmaceutical Excipients Market at 6.8% CAGR by 2031
Pharmaceutical Excipients Market Pharmaceutical Excipients Market size was valued at USD 9.48 billion in 2022 and is poised to grow from USD 10.12 billion in 2023 to USD 17.13 billion by 2031, growing at a CAGR of 6.8% in the forecast period (2024-2031). Pharmaceutical Excipients Market size was valued at USD 10.12 billion in 2023 […]